Global Liposome Excipient Market Worth $ 1.1 Billion by 2021

Date: 2018-07-11

A liposome is a spherical vesicle having at least one lipid bilayer. The liposome can be used as a vehicle for administration of nutrients and pharmaceutical drugs. Liposomes can be prepared by disrupting biological membranes. Liposome Excipient includes Phospholipids and Cholesterol on the base of classification, which represent 69.4% and 25.1% of global Liposome Excipient market. 

Tablets, Capsules, Injections and Oral liquids are the main application of Liposome Excipient product and North American is the largest Liposome Excipient market on production and consumption.

Global Liposome Excipient market is projected to reach $ 1.1 Billion by 2021, with a GAGR of 6.1% from 2017, and Asia will have a big dynamic momentum on the market growth. The major players in the global Liposome Excipient market are Nippon, Kewpie, Avanti, Nanocs, Transferra, CordenPharma, Nof Europe etc.

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample